Pacira BioSciences, Inc. (NASDAQ:PCRX) Receives $26.44 Average Price Target from Brokerages
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) has earned a consensus rating of “Hold” from the nine analysts that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, four have given a hold rating and four have assigned a buy rating to the company. […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) has earned a consensus rating of “Hold” from the nine analysts that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, four have given a hold rating and four have assigned a buy rating to the company. […]
